NexgenRx Inc (TSE:NXG) has released an update.
NexgenRx Inc. has successfully concluded its annual and special meeting, with shareholders passing all resolutions and representing nearly 60% of the company’s issued shares. Despite a unique occurrence where Director Charles Burns received a higher number of ‘Withheld’ votes than ‘For’ votes, leading to his offered resignation, the company has deferred acceptance until a suitable replacement is found by September 30, 2024. NexgenRx continues to pride itself on providing innovative health benefit technology and administration solutions in a cost-effective model.
For further insights into TSE:NXG stock, check out TipRanks’ Stock Analysis page.
